141 related articles for article (PubMed ID: 12054692)
1. RCAS1 is associated with ductal breast cancer progression.
Rousseau J; Têtu B; Caron D; Malenfant P; Cattaruzzi P; Audette M; Doillon C; Tremblay JP; Guérette B
Biochem Biophys Res Commun; 2002 May; 293(5):1544-9. PubMed ID: 12054692
[TBL] [Abstract][Full Text] [Related]
2. Expression of RCAS1 and its function in human squamous cell carcinoma of the oral cavity.
Fukuda M; Tanaka A; Hamao A; Suzuki S; Kusama K; Sakashita H
Oncol Rep; 2004 Aug; 12(2):259-67. PubMed ID: 15254686
[TBL] [Abstract][Full Text] [Related]
3. Biologic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) as a pivotal regulator of tumor growth through angiogenesis in human uterine cancer.
Sonoda K; Miyamoto S; Yamazaki A; Kobayashi H; Nakashima M; Mekada E; Wake N
Cancer; 2007 Nov; 110(9):1979-90. PubMed ID: 17849467
[TBL] [Abstract][Full Text] [Related]
4. Receptor-binding cancer antigen expressed on SiSo cells induces apoptosis via ectodomain shedding.
Sonoda K; Miyamoto S; Nakashima M; Wake N
Exp Cell Res; 2010 Jul; 316(11):1795-803. PubMed ID: 20079734
[TBL] [Abstract][Full Text] [Related]
5. RCAS1 as a tumour progression marker: an independent negative prognostic factor in gallbladder cancer.
Oshikiri T; Hida Y; Miyamoto M; Hashida H; Katoh K; Suzuoki M; Nakakubo Y; Hiraoka K; Shinohara T; Itoh T; Kondo S; Katoh H
Br J Cancer; 2001 Dec; 85(12):1922-7. PubMed ID: 11747335
[TBL] [Abstract][Full Text] [Related]
6. Overrepresentation of the EBAG9 gene at 8q23 associated with early-stage breast cancers.
Tsuneizumi M; Emi M; Nagai H; Harada H; Sakamoto G; Kasumi F; Inoue S; Kazui T; Nakamura Y
Clin Cancer Res; 2001 Nov; 7(11):3526-32. PubMed ID: 11705872
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1.
Nakashima M; Sonoda K; Watanabe T
Nat Med; 1999 Aug; 5(8):938-42. PubMed ID: 10426319
[TBL] [Abstract][Full Text] [Related]
8. A highly polymorphic CA repeat marker at the EBAG9/RCAS1 locus on 8q23 that detected frequent multiplication in breast cancer.
Tsuneizumi M; Nagai H; Harada H; Kazui T; Emi M
Ann Hum Biol; 2002; 29(4):457-60. PubMed ID: 12160478
[TBL] [Abstract][Full Text] [Related]
9. The metallothionein and RCAS1 expression analysis in breast cancer and adjacent tissue regarding the immune cells presence and their activity.
Popiela TJ; Rudnicka-Sosin L; Dutsch-Wicherek M; Klimek M; Basta P; Galazka K; Wicherek L
Neuro Endocrinol Lett; 2006 Dec; 27(6):786-94. PubMed ID: 17187007
[TBL] [Abstract][Full Text] [Related]
10. Clinico-pathological significance of RCAS1 expression in gliomas: a potential mechanism of tumor immune escape.
Nakabayashi H; Nakashima M; Hara M; Toyonaga S; Yamada SM; Park KC; Shimizu K
Cancer Lett; 2007 Feb; 246(1-2):182-9. PubMed ID: 16595162
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
12. Reevaluation of the 22-1-1 antibody and its putative antigen, EBAG9/RCAS1, as a tumor marker.
Reimer TA; Anagnostopoulos I; Erdmann B; Lehmann I; Stein H; Daniel P; Dörken B; Rehm A
BMC Cancer; 2005 May; 5():47. PubMed ID: 15904507
[TBL] [Abstract][Full Text] [Related]
13. [Expression of receptor-binding cancer antigen expressed on SiSo cells in endometrial carcinoma and the correlation thereof with the expression of estrogen receptor subtypes].
Zhou XH; Xu ST; Song WY; Teng XD
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1900-3. PubMed ID: 17923013
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of RCAS1 level in neoplasms and placenta.
Wicherek L; Dutsch M; Mak P; Klimek M; Skladzien J; Dubin A
Acta Biochim Pol; 2003; 50(4):1187-94. PubMed ID: 14740005
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning and characterization of mouse EBAG9, homolog of a human cancer associated surface antigen: expression and regulation by estrogen.
Tsuchiya F; Ikeda K; Tsutsumi O; Hiroi H; Momoeda M; Taketani Y; Muramatsu M; Inoue S
Biochem Biophys Res Commun; 2001 Jun; 284(1):2-10. PubMed ID: 11374862
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of RCAS1 expression by RNA interference recovers T cell growth and proliferation.
Han Y; Qin W; Huang G
Cancer Lett; 2007 Nov; 257(2):182-90. PubMed ID: 17825484
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of RCAS1 as a biomarker of ovarian cancer.
Sonoda K; Miyamoto S; Yotsumoto F; Yagi H; Nakashima M; Watanabe T; Nakano H
Oncol Rep; 2007 Mar; 17(3):623-8. PubMed ID: 17273743
[TBL] [Abstract][Full Text] [Related]
18. Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis.
Kato H; Nakajima M; Masuda N; Faried A; Sohda M; Fukai Y; Miyazaki T; Fukuchi M; Tsukada K; Kuwano H
J Surg Oncol; 2005 May; 90(2):89-94. PubMed ID: 15844180
[TBL] [Abstract][Full Text] [Related]
19. Protein and gene expression of tumor-associated antigen RCAS1 in esophageal squamous cell carcinoma.
Ikeguchi M; Ohoro S; Maeda Y; Yamaguchi K; Fukuda K; Shirai H; Kondo A; Tsujitani S; Kaibara N
Oncol Rep; 2003; 10(6):1891-4. PubMed ID: 14534714
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor-binding fragment-associated antigen 9 is a tumor-promoting and prognostic factor for renal cell carcinoma.
Ogushi T; Takahashi S; Takeuchi T; Urano T; Horie-Inoue K; Kumagai J; Kitamura T; Ouchi Y; Muramatsu M; Inoue S
Cancer Res; 2005 May; 65(9):3700-6. PubMed ID: 15867365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
